Special Issue "Heart Failure and Inflammation"
A special issue of Medicina (ISSN 1648-9144).
Deadline for manuscript submissions: closed (30 November 2019) | Viewed by 15537
Special Issue Editor

Interests: cardiorenal and spleno cardiac relationship; heart failure; metabolic signaling; immune kinetics; lipid mediators; metabolites; resolution of inflammation; lipoxygenase signaling
Special Issue Information
Dear Colleagues,
Heart failure (HF) is one of the most common disorders, impacting nearly 5.7 million adults in the United States. HF costs the nation an estimated $30.7 billion each year. This total includes the cost of health care services and medications to treat HF. Unresolved inflammation is one of the underlying causes of HF. In HF pathology, there is a consistent increase in the number of cytokines and chemokines that are hallmarks of chronic inflammation and kidney dysfunction. Thus, inflammation is one of the most critical causes in HF. The journal Medicina is launching a Special Issue entitled “Heart Failure and Inflammation” with the aim of gathering accurate and up-to-date scientific information which will further strengthen our knowledge about inflammation and HF. We are pleased to invite you and your co-workers to submit your original research articles reporting on the chemokine and molecular aspects of HF, including the pathophysiological mechanisms. We also encourage the submission of original manuscripts spanning basic and clinical research and focusing on dietary, lifestyle, and pharmacological interventions to prevent and ameliorate HF. We would also like to invite you to submit review articles aimed at providing a comprehensive overview of the recent advances in understanding the overall molecular mechanism in HF.
Prof. Vasundhara Kain
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicina is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Heart failure
- Inflammation
- Resolution of inflammation
- Chemokines Cytokines
- Immune kinetics